Kedaara Capital has made a strategic investment of $200 million in Tynor Orthotics Private Limited, acquiring a majority stake in the company. The transaction was reported on 2 September 2026. Trilegal advised Tynor, its promoters, professional management team, and existing stakeholder Lighthouse Funds in relation to the investment. The transaction team at Trilegal was led by partners Amit Khansaheb, Vishruta Kaul, and Pratyush Singh, with support from counsel Aayush Sood and senior associates Advaye Sawhny and Neha Koppu. Associates Mukund Agarwal, Akshat Jain, and Rohan Tolani also provided support. Rahul Arora, partner at Trilegal, along with senior associate Yashasvi Gupta and consultant Shivek Jhanda, advised on real estate law aspects of the transaction.
Quillon Partners advised Kedaara Capital on the investment. The transaction team at Quillon Partners was led by partners Ankit Majmudar and Shriti Shah.
Tynor Orthotics, founded in 1993, specialises in orthopaedic supports, mobility aids, rehabilitation, and sports performance enhancement solutions. The company has an extensive reach, with products available across over 300,000 retail outlets and 8,000 hospitals in 60 countries. Kedaara Capital stated that it will work closely with the promoters of Tynor, Dr. P.J. Singh and Mr. A.J. Singh, to deepen the brand’s reach across India, expand its presence in international markets, and invest in world-class, efficient manufacturing.
The investment reflects Kedaara Capital’s focus on partnering with established Indian businesses to support growth and market expansion. Trilegal and Quillon Partners provided legal counsel on the structuring, negotiation, and execution of the transaction, ensuring compliance with applicable laws and regulations governing foreign investment and corporate transactions in India.
No court or judicial authority was involved in the transaction, which was a private equity investment conducted between the parties. The legal advisory roles undertaken by Trilegal and Quillon Partners were confined to facilitating the transaction between Kedaara Capital and Tynor Orthotics, including due diligence, documentation, and regulatory clearances where required.
The transaction highlights the continued interest of private equity firms in the healthcare and medical devices sector in India, particularly in companies with strong domestic distribution networks and international footprints. Tynor’s pan-India and global presence was cited as a key factor in Kedaara Capital’s decision to invest.
Both law firms confirmed their involvement in the deal through their respective professional networks, with Trilegal emphasizing its advisory role for the company and its stakeholders, and Quillon Partners confirming its representation of the investor. The financial details of the transaction, including the $200 million investment amount and the acquisition of a majority stake, were disclosed in the public announcement.
No litigation, regulatory intervention, or judicial observation formed part of this transaction. The matter remains a private commercial agreement between the investor and the company, facilitated by legal counsel on both sides.